Dr. Hazera Khatun joined the Division of Hospital Medicine as an Instructor in Medicine in July 2024. She earned her MBBS degree from Dhaka Medical College in Bangladesh and completed her hematology training, receiving a fellowship from BCPS. Dr. Khatun has published multiple articles in clinical research on hematology. She obtained an MSc in Biomedical Sciences from King’s College London, UK, as a Commonwealth Scholar. In the USA, she completed her residency in Internal Medicine and has been practicing as a full-time hospitalist since 2019. Dr. Khatun also has a keen interest in clinical education and briefly taught as a Clinical Assistant Professor at the Warren Alpert School of Medicine.
Education
- MBBS: Dhaka Medical College and Hospital, Bangladesh (2004)
- MSc, Biomedical and Molecular Sciences Research: King’s College London, UK (2010)
- Fellowship, Hematology: Bangladesh College of Physicians and Surgeons, Bangladesh (2012)
- Residency, Internal Medicine: Saint Michael’s Medical Center, Newark, NJ (2019)
Clinical/Research Interests
Inpatient care, patient satisfaction, quality improvement, and end of life care, clinical and translational research on hematologic malignancies
Publications
Khatun H, Murari U, Chittamuri S, Shaaban H. A Unique Case of Mammary Analog Secretory Carcinoma of the Thyroid Gland Poster presentation at NEOMEN’s 18th Annual Research and Scholarship Forum. Maine, USA. May 16,2019.
Kaur S, Khatun H, Kumar A, Ellis M, Mehta D, Guron G (2018) Cetuximab Induced Aseptic Meningitis: A Rare Side Effect. J Cancer Sci Ther 10: 211-213. https://www.hilarispublisher.com/open-access/cetuximab-induced-aseptic-meningitis-a-rare-side-effect-1948-5956-1000546.pdf
Hossain MS, Raheem E ,Sultana TA, Ferdous S, Nahar N, Islam S, Arifuzzaman M, Razzaque MA, Alam R, Aziz S, Khatun H, Rahim A, Morshed M. Thalassemias in South Asia: clinical lessons learnt from Bangladesh. Orphanet J Rare Dis. 2017 May 18;12(1):93. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437604/
Islam MM, Rahman MM, Ferdous J, Akter M, Nazneen H, Ali M, Nazneen S, Ahmed SM, Khan MA, Salma S, Ara T, Biswas AR, Khatun H, Dilshad D. Outcome of Standard Induction Therapy with Daunorubicin and Ara-C (3+7) in Acute Myeloid Leukemia. J Dhaka Med Coll. 2016 Sep. 15;24(2):141-5. DOI: 10.3329/jdmc.v24i2.29626
Khatun H, Morshed M and Anam S. Induction in adult acute lymphoblastic leukemia: a study of 22 cases. J Bangladesh Coll Phys Surg 2015; 33:18-22. . https://doi.org/10.3329/jbcps.v33i1.27995
Khatun H, Morshed M. Thrombotic Thrombocytopenic Purpura: Issues in Diagnosis and Treatment. Mymensingh Med J. 2015 Oct;24(4):761-4.https://www.ncbi.nlm.nih.gov/pubmed/26620016
Hossain, MS, Iqbal MS, Sultana TA, Khatun H, Khan MA, Rabbani MG, Kabir AL et al. Diagnosed hematological malignancies in Bangladesh – a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer. 2014; 14: 438. https://www.ncbi.nlm.nih.gov/pubmed/24929433
Khatun H, Afrose S, Khan MA, Ara T, Islam MS. Cold agglutinin disease secondary to multiple myeloma in a psoriatic patient. J medicine. 2014; 15: 141-143 10.3329/jom.v15i2.20688
Khatun H, Khan MA, Afrose S, Ara T, Islam M S , Biswas A R . Bone marrow trephine biopsy in hematological diseases: A study of 53 cases. J Dhaka Med Coll. 2013;22(2):207210. 10.3329/jdmc.v22i2.21544
Ramasamy, K., Khatun, H., Macpherson, L., Caley, M. P., Sturge, J., Mufti, G. J., Schey, S. A. and Calle, Y. Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells. BJH.2012; 157(5): 564-579.https://www.ncbi.nlm.nih.gov/pubmed/22428569
Khatun, H., Anwar, A., Kazmi, M. A., Schey, S. & Calle, Y. The Wiskott Aldrich Syndrome Protein (WASP) Is Involved in Dexamethasone-Signalling Pathways Leading to Apoptosis of Multiple Myeloma Cells and in Cell Adhesion Mediated Drug Resistance Against Dexamethasone. Blood (2011) 118 (21):1809 .https://doi.org/10.1182/blood.V118.21.1809.1809
Ramasamy, K., Khatun, H., Macpherson, L., Mufti, G. J., Schey, S. & Calle, Y. Direct Effect on the Stroma by the Conventional Anti-Multiple Myeloma Drug Dexamethasone Results In Resistance of Multiple Myeloma plasma Cells Against Therapy. Sensitisation to Dexamethasone by the Kinase Inhibitor Dasatinib. Blood. 2010; 116 (21):1931. https://doi.org/10.1182/blood.V116.21.1931.1931